15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for CNA yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $47.77 current
Highest Target—
Average Target—
Lowest Target—
CNA analyst recommendation trends
86420
Sep
Oct
Nov
Dec
Jan
Strong BuyBuyHoldSellStrong Sell
RATING
SEP
OCT
NOV
DEC
JAN
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
1
1
1
1
1
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
Total
2
1
1
1
1
As of Jan, 0 of 1 firms rate CNA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CNA EPS & revenue forecast
EPS · NEXT QUARTER
$1.09
Range $1.09 – $1.09 · 1 analysts · -6% YoY
Next period, 1 analysts expect CNA Financial Corporation to earn $1.09 a share (range $1.09 – $1.09), versus $1.16 a year earlier. Full-year consensus is $4.30, growing to $4.80 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering CNA Financial Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CNA.
#1
Meyer Shields
Keefe, Bruyette & Woods · Rank #254
Hold
$53.00+10.9% to target
Overall win rate
40%
+ Follow
#2
JS
Joshua Shanker
B of A Securities
Sell
$48.00+0.5% to target
Coverage
—
+ Follow
CNA stock forecast FAQ
Who is the most accurate analyst covering CNA?+
Among analysts who currently cover CNA, Meyer Shields of Keefe, Bruyette & Woods has the strongest overall Quantellect track record (Rank #254). Their current call is Hold with a $53.00 target.
What is CNA Financial Corporation's projected EPS for next quarter?+
The consensus estimate is $1.09 per share (range $1.09 – $1.09) across 1 analysts. Full-year EPS is projected at $4.30, rising to $4.80 the following year.
How much revenue is CNA Financial Corporation expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading CNA lately?+
As of Jan, 0 of 1 firms rate CNA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CNA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
